Specify a stock or a cryptocurrency in the search bar to get a summary
Hisamitsu Pharmaceutical Inc
4530Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Address: Tashirodaikan-machi 408, Tosu, Japan, 841-0017
Analytics
WallStreet Target Price
694 507.68 JPYP/E ratio
21.782Dividend Yield
1.09 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4530
Dividend Analytics 4530
Dividend growth over 5 years
-48 %Continuous growth
1 yearPayout Ratio 5 years average
41 %Dividend History 4530
Stock Valuation 4530
Financials 4530
Results | 2019 | Dynamics |